Next, the expression of common hypoxia-inducible genes (CA9, SLC2A1, and PDK1) was evaluated in vehicle- and sorafenib-treated ccRCC xenografts. The gene discussed is SLC2A1; the disease is nonpapillary renal cell carcinoma.